.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Poster Session

Poster Session II

even poster ID´s

Termin

Datum: Di, 28.05.2024

Zeit: 17:30 – 19:00

Ort / Stream:

Meitner-Saal I+II & Planck-Lobby

Programm

Poster presentation
P002
Immunization with the amino-terminus region of dense granule protein 6 (GRA6) of Toxoplasma gondii activates CD8+ cytotoxic T cells capable of removing tissue cysts of the parasite through antigen presentation by human HLA-A2.1
Dr. Rajesh Mani (Lexington, VT / US)
Immunology of Acute & Chronic Infection
Poster presentation
P006
Preliminary data of a time-controlled splitCas9 genome wide screen in Toxoplasma gondii
Ella Schadt (Planegg / DE)
Genomics
Poster presentation
P008
Stage-specific gene expression and signaling through chromatin: the paradigmatic interplay of Toxoplasma GCN5b and HDAC3
Dominique Cannella (Grenoble / FR)
Genomics
Poster presentation
P010
Anti-Apicomplexa drug discovery: Chemotherapeutic drug screening and target deconvolution in Toxoplasma gondii.
Dr. Laurence Braun (La Tronche / FR)
Alexandre Bougdour (La Tronche / FR)
Metabolism, Biochemistry & Drug Development
Poster presentation
P012
Structural insight into the apicomplexan drug target cytochrome bc1
Dr. Andrew Maclean (Glasgow / GB)
Metabolism, Biochemistry & Drug Development
Poster presentation
P014
Establishment of an E. coli model for studying the interaction and flexibility of apicoplast resident ferredoxin and bacterial flavodoxin redox systems towards IspH of the isoprenoid pathway
Ojo-Ajogu Akuh (Berlin / DE)
Metabolism, Biochemistry & Drug Development
Poster presentation
P016
Biochemical mutagenesis signatures systematically identify functional palmitoylation post-translational modifications in Toxoplasma gondii
Dr. Matthew Child (London / GB)
Host-Parasite Interaction & Signalling
Poster presentation
P018
Exploring the Seroprevalence and Molecular Epidemiology of Toxoplasma gondii in Sheep Populations of Uruguay
Leandro Tana-Hernández (Montevideo / UY)
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Poster presentation
P022
Cross linking mass spectrometry: A new tool for studies on the Toxoplasma gondii protein interactome
Dr. Tadikimi Tomita (Bronx / US)
Metabolism, Biochemistry & Drug Development
Poster presentation
P024
Identifying novel proteins that function in the regulation of arginine uptake in Toxoplasma gondii
Professor Giel G. van Dooren (Canberra / AU)
Host-Parasite Interaction & Signalling
Poster presentation
P026
Critical roles of an oxysterol-binding protein in lipid synthesis and trafficking in Toxoplasma gondii
Qin Biyun (Wuhan，China / CN)
Metabolism, Biochemistry & Drug Development
Poster presentation
P028
Insights into the formation of the Toxoplasma plant-like vacuolar compartment
Professor Vernon B. Carruthers (Ann Arbor, MI / US)
Cell Biology
Poster presentation
P030
The role of NETosis and ROS production in human neutrophil-mediated host defense against Toxoplasma gondii infection
Dr. Tatiane Lima (Pomona / US)
Innate Immunity and Immune Evasion
Poster presentation
P032
First report of isolation of Toxoplasma gondii from Franciscana dolphin (Pontoporia blainvillei) in the South Coast of State of Santa Catarina, Brazil
Professor Anderson Barbosa de Moura (Lages / BR)
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Poster presentation
P034
DNA VACCINE ENCODING THE ROP18 GENE OF Toxoplasma gondii AGAINST OOCYSTS SHEDDING IN DOMESTIC CATS
Professor João Luís Garcia (Londrina / BR)
Host-Parasite Interaction & Signalling
Poster presentation
P036
Activity and efficacy of the bumped kinase inhibitor BKI-1708 in vitro and in non-pregnant and pregnant toxoplasmosis and neosporosis mouse models
Maria Ferreira de Sousa (Bern / CH)
Metabolism, Biochemistry & Drug Development
Poster presentation
P038
TgGloL is an atypical glyoxalase domain-containing apicoplast protein that is important for the growth of Toxoplasma
Dr. Sébastien Besteiro (Montpellier / FR)
Metabolism, Biochemistry & Drug Development
Poster presentation
P040
Exploiting Host Endoplasmic Reticulum: Toxoplasma gondii's Strategy for Amino Acid Acquisition and Brain Persistence
Leonardo Augusto (Omaha / US)
Host-Parasite Interaction & Signalling
Poster presentation
P042
Isolation and analysis of Toxoplasma gondii from a Japanese patient with congenital toxoplasmosis
Dr. Kisaburo Nagamune (Shinjuku-ku, Tokyo / JP)
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Poster presentation
P044
The Toxoplasma PQ-loop protein TgMPDU1 is essential for efficient parasite C-mannosylation
Dr. Federica Piro (Perugia / IT)
Intracellular Replication & Survival
Poster presentation
P046
In vitro evaluation of natural compounds extracts from Tabebuia against Toxoplasma gondii proliferation
Professor Jorge Enrique Gómez Marin (Armenia / CO)
Metabolism, Biochemistry & Drug Development
Poster presentation
P048
Unraveling Morphological and Biomechanical Responses to Harsh Environmental Conditions in Coccidian Oocysts
Jana Elhusseiny (Marseille / FR)
Cell Biology
Poster presentation
P050
Toxoplasma resistance to mucin 2 and human cathelicidin LL-37
Dr. Pascale Guiton (Santa Clara / US)
Host-Parasite Interaction & Signalling
Poster presentation
P052
Susceptibility of eight Brazilian human isolates of Toxoplasma gondii to Sulfadiazine and Pyrimethamine
Dr. Erica Martins Duarte (Belo Horizonte / BR)
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Poster presentation
P054
Host cell traversal by Toxoplasma gondii sporozoites: evidence of an unprecedented force-producing mechanism
Professor Furio Spano (Rome / IT)
Cell Biology
Poster presentation
P056
Comparative proteomic analysis of Toxoplasma gondii Me49-derived strains adapted to in vitro treatments with thiosemicarbazones
Manuela Semeraro (Parma / IT)
Metabolism, Biochemistry & Drug Development
Poster presentation
P058
Fatal systemic toxoplasmosis with atypical steatitis in southern sea otters (Enhydra lutris nereis) associated with the COUG (TgCgCa1) strain
Dr. Devinn Sinnott (Davis / US)
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Poster presentation
P060
The Impact of Host Arginine Metabolism on Toxoplasma gondii Infection and Growth Dynamics.
Katie Barnes (Madison / US)
Intracellular Replication & Survival